Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Cogent Biosciences (COGT) Operating Margin (2017 - 2020)

Cogent Biosciences' Operating Margin history spans 4 years, with the latest figure at 18333.01% for Q3 2020.

  • Quarterly Operating Margin fell 1715301.0% to 18333.01% in Q3 2020 from the year-ago period, while the trailing twelve-month figure was 1044.33% through Dec 2020, down 90131.0% year-over-year, with the annual reading at 1044.33% for FY2020, 90131.0% down from the prior year.
  • Operating Margin came in at 18333.01% for Q3 2020, down from 1402.08% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 14.65% in Q4 2019 to a low of 18333.01% in Q3 2020.
  • The 4-year median for Operating Margin is 332.18% (2017), against an average of 1640.08%.
  • The largest YoY upside for Operating Margin was 30051bps in 2020 against a maximum downside of -1715301bps in 2020.
  • Cogent Biosciences' Operating Margin stood at 324.07% in 2017, then rose by 27bps to 236.64% in 2018, then soared by 106bps to 14.65% in 2019, then tumbled by -125223bps to 18333.01% in 2020.
  • Per Business Quant, the three most recent readings for COGT's Operating Margin are 18333.01% (Q3 2020), 1402.08% (Q2 2020), and 87.34% (Q1 2020).